FindTrial
Sign In

Association Study of Perfluorinated Compound Exposure and Preterm Birth Risk

Association Study of Perfluorinated Compound Exposure and Preterm Birth Risk: Mediation Effect Analysis of DNA Methylation Mechanism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119068
Enrollment
Unknown
Registered
2026-02-14
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm birth

Interventions

case group:NA
Healthy control group:NA

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Case group: 1. Singleton premature infants; 2. Complete clinical information and biological samples; 3. Guardians consented to participate in the study and signed informed consent forms. Healthy control group: 1. Singleton newborns; 2. Complete clinical information and biological samples; 3. Guardians consented to participate in the study and signed informed consent forms.

Exclusion criteria

Exclusion criteria: 1.Exclude newborns suffering from complex congenital heart disease or inherited metabolic disorders.

Design outcomes

Primary

MeasureTime frame
Perfluorinated compounds, DNA methylation;—

Countries

China

Contacts

Public ContactJing Liu

China-Japan Friendship Hospital

liujing906@163.com+86 10 84206180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026